432 related articles for article (PubMed ID: 21971001)
1. Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence.
Bortolato M; Shih JC
Int Rev Neurobiol; 2011; 100():13-42. PubMed ID: 21971001
[TBL] [Abstract][Full Text] [Related]
2. Modulation of monoamine oxidase (MAO) expression in neuropsychiatric disorders: genetic and environmental factors involved in type A MAO expression.
Naoi M; Riederer P; Maruyama W
J Neural Transm (Vienna); 2016 Feb; 123(2):91-106. PubMed ID: 25604428
[TBL] [Abstract][Full Text] [Related]
3. Plasma amine oxidase activities in Norrie disease patients with an X-chromosomal deletion affecting monoamine oxidase.
Murphy DL; Sims KB; Karoum F; Garrick NA; de la Chapelle A; Sankila EM; Norio R; Breakefield XO
J Neural Transm Gen Sect; 1991; 83(1-2):1-12. PubMed ID: 2018626
[TBL] [Abstract][Full Text] [Related]
4. Monoamine oxidase inactivation: from pathophysiology to therapeutics.
Bortolato M; Chen K; Shih JC
Adv Drug Deliv Rev; 2008; 60(13-14):1527-33. PubMed ID: 18652859
[TBL] [Abstract][Full Text] [Related]
5. From aggression to autism: new perspectives on the behavioral sequelae of monoamine oxidase deficiency.
Bortolato M; Floris G; Shih JC
J Neural Transm (Vienna); 2018 Nov; 125(11):1589-1599. PubMed ID: 29748850
[TBL] [Abstract][Full Text] [Related]
6. Progress in monoamine oxidase (MAO) research in relation to genetic engineering.
Nagatsu T
Neurotoxicology; 2004 Jan; 25(1-2):11-20. PubMed ID: 14697876
[TBL] [Abstract][Full Text] [Related]
7. Monoamine oxidase (MAO) activity as a determinant in human neurophysiology.
Pintar JE; Breakefield XO
Behav Genet; 1982 Feb; 12(1):53-68. PubMed ID: 6284115
[TBL] [Abstract][Full Text] [Related]
8. Specific genetic deficiencies of the A and B isoenzymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes.
Lenders JW; Eisenhofer G; Abeling NG; Berger W; Murphy DL; Konings CH; Wagemakers LM; Kopin IJ; Karoum F; van Gennip AH; Brunner HG
J Clin Invest; 1996 Feb; 97(4):1010-9. PubMed ID: 8613523
[TBL] [Abstract][Full Text] [Related]
9. NEUROBIOLOGICAL BASES OF ALCOHOL ADDICTION.
Matošić A; Marušić S; Vidrih B; Kovak-Mufić A; Cicin-Šain L
Acta Clin Croat; 2016 Mar; 55(1):134-50. PubMed ID: 27333729
[TBL] [Abstract][Full Text] [Related]
10. Behavioral disinhibition and reduced anxiety-like behaviors in monoamine oxidase B-deficient mice.
Bortolato M; Godar SC; Davarian S; Chen K; Shih JC
Neuropsychopharmacology; 2009 Dec; 34(13):2746-57. PubMed ID: 19710633
[TBL] [Abstract][Full Text] [Related]
11. Phenethylamine is a substrate of monoamine oxidase B in the paraventricular thalamic nucleus.
Obata Y; Kubota-Sakashita M; Kasahara T; Mizuno M; Nemoto T; Kato T
Sci Rep; 2022 Jan; 12(1):17. PubMed ID: 34996979
[TBL] [Abstract][Full Text] [Related]
12. Monoamine oxidase: from genes to behavior.
Shih JC; Chen K; Ridd MJ
Annu Rev Neurosci; 1999; 22():197-217. PubMed ID: 10202537
[TBL] [Abstract][Full Text] [Related]
13. Social deficits and perseverative behaviors, but not overt aggression, in MAO-A hypomorphic mice.
Bortolato M; Chen K; Godar SC; Chen G; Wu W; Rebrin I; Farrell MR; Scott AL; Wellman CL; Shih JC
Neuropsychopharmacology; 2011 Dec; 36(13):2674-88. PubMed ID: 21832987
[TBL] [Abstract][Full Text] [Related]
14. Specificity of endogenous substrates for types A and B monoamine oxidase in rat striatum.
Schoepp DD; Azzaro AJ
J Neurochem; 1981 Jun; 36(6):2025-31. PubMed ID: 6787175
[TBL] [Abstract][Full Text] [Related]
15. Are MAO-A deficiency states in the general population and in putative high-risk populations highly uncommon?
Murphy DL; Sims K; Eisenhofer G; Greenberg BD; George T; Berlin F; Zametkin A; Ernst M; Breakefield XO
J Neural Transm Suppl; 1998; 52():29-38. PubMed ID: 9564605
[TBL] [Abstract][Full Text] [Related]
16. Brain injury and inflammation genes common to a number of neurological diseases and the genes involved in the genesis of GABAnergic neurons are altered in monoamine oxidase B knockout mice.
Chen K; Palagashvili T; Hsu W; Chen Y; Tabakoff B; Hong F; Shih AT; Shih JC
Brain Res; 2022 Jan; 1774():147724. PubMed ID: 34780749
[TBL] [Abstract][Full Text] [Related]
17. SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.
Aubin N; Barneoud P; Carter C; Caille D; Sontag N; Marc C; Lolivier J; Gardes A; Perron C; Le Kim A; Charieras T; Pandini M; Burnier P; Puech F; Jegham S; George P; Scatton B; Curet O
J Pharmacol Exp Ther; 2004 Sep; 310(3):1171-82. PubMed ID: 15178694
[TBL] [Abstract][Full Text] [Related]
18. [Effect of benzamide derivatives on rat brain monoamine oxidase activity in vitro].
Gol'dina OA; Zagorevskiĭ VA; Lopatina KI; Sokolova TV; Gankina EM
Biull Eksp Biol Med; 1986 Aug; 102(8):170-2. PubMed ID: 3742029
[TBL] [Abstract][Full Text] [Related]
19. NMDARs mediate the role of monoamine oxidase A in pathological aggression.
Bortolato M; Godar SC; Melis M; Soggiu A; Roncada P; Casu A; Flore G; Chen K; Frau R; Urbani A; Castelli MP; Devoto P; Shih JC
J Neurosci; 2012 Jun; 32(25):8574-82. PubMed ID: 22723698
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional regulation and multiple functions of MAO genes.
Shih JC; Wu JB; Chen K
J Neural Transm (Vienna); 2011 Jul; 118(7):979-86. PubMed ID: 21359973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
